Free shipping on all orders over $ 500

BAR 502

Cat. No. M5256
BAR 502 Structure
Size Price Availability Quantity
5mg USD 350  USD350 In stock
10mg USD 500  USD500 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

BAR502 is a dual agonist of FXR and GPBAR1 with IC50 values of 2 μM and 0.4 μM, respectively.

Chemical Information
Molecular Weight 392.62
Formula C25H44O3
CAS Number 1612191-86-2
Form Solid
Solubility (25°C) 10mM in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Marc-Olivier Fischer, et al. Pleth Variability Index in Orthopedic Surgery: Reply

[2] No authors listed. Phenobarbital

[3] Jerod S Denton, et al. Plight of the pore polar bar(rier)

[4] Anna Mary Bowers, et al. Impact of Bar-code Medication Administration on Medication Administration Best Practices

[5] Eric W Fonkalsrud. Current management of pectus excavatum

Related GPCR19/TGR5 Products
Ursodeoxycholic acid sodium

Ursodeoxycholic acid (Ursodeoxycholate) sodium is a secondary bile acid issued from the transformation of (cheno)deoxycholic acid by intestinal bacteria, acting as a key regulator of the intestinal barrier integrity and essential for lipid metabolism.

SB756050

SB756050 is a selective TGR5 agonist. SB756050 has the potential for type 2 diabetes treatment.

Deoxycholic acid sodium salt

Deoxycholic acid sodium salt activates the G protein-coupled bile acid receptor TGR5.

SBI-115

SBI-115 is a TGR5 (GPCR19) antagonist, it decreases hepatic cystogenesis with polycystic liver diseases via inhibiting TGR5.

INT-777

INT-777 is a potent TGR5 agonist with EC50 of 0.82 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: BAR 502 supplier, GPCR19/TGR5, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.